Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annalisa Aratari

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Journal of Gastrointestinal and Liver Diseases : JGLD|March 30, 2012
Early treatment in Crohn's disease: do we have enough evidence to reverse the therapeutic pyramid?Federica Fascì Spurio, Annalisa Aratari, Giovanna Margagnoni, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 8, 2020
Acute kidney injury: an unexpected Isoniazid-related adverse event in a patient with Crohn's disease receiving prophylactic treatment for latent tuberculosisFabiola De Biasio, Annalisa Aratari, Sara Caporuscio, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|March 30, 2013
Low bioavailability and traditional systemic steroids in IBD: can the former take over the latter?Federica Fasci Spurio, Annalisa Aratari, Giovanna Margagnoni, et al.
Recenti Progressi in Medicina|May 18, 2021
What are the challenges in selecting pharmacotherapy for pregnant women with inflammatory bowel disease?Annalisa Aratari, Giulia Zerboni, Fabiola De Biasio, et al.
Current Clinical Pharmacology|March 22, 2012
Oral beclomethasone dipropionate: a critical review of its use in the management of ulcerative colitis and Crohn's diseaseFederica Fascì Spurio, Annalisa Aratari, Giovanna Margagnoni, et al.
Digestive Diseases and Sciences|November 26, 2009
Oral beclomethasone dipropionate as an alternative to systemic steroids in mild to moderate ulcerative colitis not responding to aminosalicylatesClaudio Papi, Annalisa Aratari, Alessandra Moretti, et al.
Frontiers in Nutrition|January 27, 2023
Should the Mediterranean diet be recommended for inflammatory bowel diseases patients? A narrative reviewAlicja Ewa Ratajczak, Stefano Festa, Annalisa Aratari, et al.
Clinical Endoscopy|November 2, 2023
Stricturing Crohn's disease: what is the role of endoscopic stenting? A systematic reviewGiorgia Burrelli Scotti, Roberto Lorenzetti, Annalisa Aratari, et al.
Internal and Emergency Medicine|April 23, 2010
A study on QT interval in patients affected with inflammatory bowel disease without cardiac involvementMario Curione, Annalisa Aratari, Silvia Amato, et al.
Recenti Progressi in Medicina|June 11, 2013
[Prevention of post-operative recurrence in Crohn's disease: a critical review of randomized controlled trials and meta-analyses of different therapeutic strategies]Giovanna Margagnoni, Valeria Clemente, Annalisa Aratari, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Journal of Gastrointestinal and Liver Diseases : JGLD|March 30, 2012
Early treatment in Crohn's disease: do we have enough evidence to reverse the therapeutic pyramid?Federica Fascì Spurio, Annalisa Aratari, Giovanna Margagnoni, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 8, 2020
Acute kidney injury: an unexpected Isoniazid-related adverse event in a patient with Crohn's disease receiving prophylactic treatment for latent tuberculosisFabiola De Biasio, Annalisa Aratari, Sara Caporuscio, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|March 30, 2013
Low bioavailability and traditional systemic steroids in IBD: can the former take over the latter?Federica Fasci Spurio, Annalisa Aratari, Giovanna Margagnoni, et al.
Recenti Progressi in Medicina|May 18, 2021
What are the challenges in selecting pharmacotherapy for pregnant women with inflammatory bowel disease?Annalisa Aratari, Giulia Zerboni, Fabiola De Biasio, et al.
Current Clinical Pharmacology|March 22, 2012
Oral beclomethasone dipropionate: a critical review of its use in the management of ulcerative colitis and Crohn's diseaseFederica Fascì Spurio, Annalisa Aratari, Giovanna Margagnoni, et al.
Digestive Diseases and Sciences|November 26, 2009
Oral beclomethasone dipropionate as an alternative to systemic steroids in mild to moderate ulcerative colitis not responding to aminosalicylatesClaudio Papi, Annalisa Aratari, Alessandra Moretti, et al.
Frontiers in Nutrition|January 27, 2023
Should the Mediterranean diet be recommended for inflammatory bowel diseases patients? A narrative reviewAlicja Ewa Ratajczak, Stefano Festa, Annalisa Aratari, et al.
Clinical Endoscopy|November 2, 2023
Stricturing Crohn's disease: what is the role of endoscopic stenting? A systematic reviewGiorgia Burrelli Scotti, Roberto Lorenzetti, Annalisa Aratari, et al.
Internal and Emergency Medicine|April 23, 2010
A study on QT interval in patients affected with inflammatory bowel disease without cardiac involvementMario Curione, Annalisa Aratari, Silvia Amato, et al.
Recenti Progressi in Medicina|June 11, 2013
[Prevention of post-operative recurrence in Crohn's disease: a critical review of randomized controlled trials and meta-analyses of different therapeutic strategies]Giovanna Margagnoni, Valeria Clemente, Annalisa Aratari, et al.
Pageof 6